Cover Image
市場調查報告書

心室中隔缺損:全球臨床實驗檢討

Ventricular Septal Defect Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 316094
出版日期 內容資訊 英文 57 Pages
訂單完成後即時交付
價格
Back to Top
心室中隔缺損:全球臨床實驗檢討 Ventricular Septal Defect Global Clinical Trials Review, H2, 2014
出版日期: 2014年09月30日 內容資訊: 英文 57 Pages
簡介

心室中隔缺損是先天性的心臟疾病,是心室中隔有破損的疾病。

本報告提供心室中隔缺損的臨床試驗相關之基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,進行臨床試驗的主要製藥企業及研究機關簡介等資訊。

簡介

  • 心室中隔缺損
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5個國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量

G7各國臨床實驗數量:心血管疾病治療藥臨床實驗中,心室中隔缺損治療藥所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:心室中隔缺損治療藥的心血管疾病治療藥臨床實驗中,比率

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

參與心室中隔缺損治療藥臨床實驗的主要企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Asklepion Pharmaceuticals, LLC
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Heart, Lung, and Blood Institute
    • Union Hospital
    • Helsinki University Central Hospital
    • Aarhus University
    • Seoul National University Hospital
    • Nationwide Children's Hospital
    • National Taiwan University Hospital
    • All India Institute of Medical Sciences
    • University of Pennsylvania
    • National Center for Research Resources

5個有代表性的臨床實驗簡介

附錄

目錄

GlobalData's clinical trial report, "Ventricular Septal Defect Global Clinical Trials Review, H2, 2014" provides data on the Ventricular Septal Defect clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Septal Defect. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ventricular Septal Defect. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Ventricular Septal Defect
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Ventricular Septal Defect
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Ventricular Septal Defect Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Asklepion Pharmaceuticals, LLC
      • Clinical Trial Overview of Asklepion Pharmaceuticals, LLC
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • Union Hospital
      • Clinical Trial Overview of Union Hospital
      • Helsinki University Central Hospital
      • Clinical Trial Overview of Helsinki University Central Hospital
      • Aarhus University
      • Clinical Trial Overview of Aarhus University
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Nationwide Children's Hospital
      • Clinical Trial Overview of Nationwide Children's Hospital
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • All India Institute of Medical Sciences
      • Clinical Trial Overview of All India Institute of Medical Sciences
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Region, 2014*
  • Ventricular Septal Defect Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ventricular Septal Defect Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Ventricular Septal Defect Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ventricular Septal Defect Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Ventricular Septal Defect Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Ventricular Septal Defect Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Ventricular Septal Defect Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Ventricular Septal Defect Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ventricular Septal Defect Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Asklepion Pharmaceuticals, LLC, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Union Hospital, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Helsinki University Central Hospital, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by Nationwide Children's Hospital, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014*

List of Figures

  • Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Ventricular Septal Defect Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ventricular Septal Defect Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Ventricular Septal Defect Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ventricular Septal Defect Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Ventricular Septal Defect to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Ventricular Septal Defect Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Ventricular Septal Defect Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Ventricular Septal Defect Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Ventricular Septal Defect Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ventricular Septal Defect Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ventricular Septal Defect Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top